Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study.
Başkol Elik D, Kaya Ş, Alkan S, Demirdal T, Sener A, Kaya S, Güzel Tunçcan Ö, Kayaaslan B, Güner R, Eser F, Kahraman H, Birengel S, Sarıcaoğlu EM, Eroğlu E, Çölkesen F, Öztürk E, Berk Cam H, Mermutluoğlu Ç, Özer Balin Ş, Sincan G, Altın N, Sili U, Suntur BM, Arslan Gülen T, Deveci B, Saba R, İncecik Ş, Eser Karlıdağ G, Hakko E, Akdağ D, Erdem HA, Sipahi H, Çicek C, Taşbakan MS, Taşbakan M, Pullukçu H, Yamazhan T, Arda B, Ulusoy S, Sipahi OR. Başkol Elik D, et al. Among authors: saba r. Sci Rep. 2024 Mar 3;14(1):5218. doi: 10.1038/s41598-024-55886-w. Sci Rep. 2024. PMID: 38433274 Free PMC article.
Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Keklik M, Deveci B, Celik S, Deniz K, Gonen ZB, Zararsiz G, Saba R, Akyol G, Ozkul Y, Kaynar L, Keklik E, Unal A, Cetin M, Jones OY. Keklik M, et al. Among authors: saba r. Ann Hematol. 2023 Jun;102(6):1537-1547. doi: 10.1007/s00277-023-05216-3. Epub 2023 Apr 17. Ann Hematol. 2023. PMID: 37067556
Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.
Ataş Ü, Salim O, Iltar U, Yücel OK, Küçükdiler Eroğlu AH, Aslan V, Yıldırım M, Dedeoğlu Ö, Seçilmiş S, Ulaş T, Deveci B, Karaman Gulsaran S, Gedük A, Yaman F, Pınar İE, Maral S, Sarıcı A, Çelik S, Oğul H, Gülkan Özkan S, Gemici A, Güneş AK, Tombak A, Yavaşoğlu İ, Karakuş V, Cömert M, Toptaş T, Dal MS, Saba R, Kırkızlar HO, Mehtap Ö, Gündüz E, Özkalemkaş F, Albayrak M, Berber İ, Keklik M, Güler N, Özkan HA, Sevindik ÖG, Bolaman Z, Kurtoğlu E, Aylı M, Fıratlı Tuğlular T, Altuntaş F, Ündar L. Ataş Ü, et al. Among authors: saba r. Turk J Haematol. 2024 Dec 2;41(4):225-235. doi: 10.4274/tjh.galenos.2024.2023.0450. Epub 2024 Nov 6. Turk J Haematol. 2024. PMID: 39501735 Free PMC article.
Validation of the Portuguese MDS-UPDRS: Challenges to Obtain a Scale Applicable to Different Linguistic Cultures.
Soares T, Vale TC, Guedes LC, Maciel RO, Antunes AP, Camargos S, Valadas A, Coelho M, Godinho C, Maia D, Lobo P, Maia R, Teodoro T, Rieder C, Velon AG, Rosas MJ, Calado A, Caniça V, Vale J, Mendes A, Rodrigues AM, Costa MM, Lampreia T, Ferraz HB, Tumas V, Barbosa E, Stebbins GT, Tilley BC, Luo S, LaPelle NR, Goetz CG, Cardoso F, Ferreira JJ; MDS‐UPDRS Portuguese Validation Study Group. Soares T, et al. Mov Disord Clin Pract. 2025 Jan;12(1):34-42. doi: 10.1002/mdc3.14236. Epub 2024 Oct 26. Mov Disord Clin Pract. 2025. PMID: 39460979
178 results